Navigation Links
Neuro Kinetics Invited to Present at NIH Forum for Investors and Strategic Partners
Date:2/14/2012

PITTSBURGH, Feb. 14, 2012 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers and marketers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/ neurotologic testing, said today that it is presenting at the National Institutes of Health's (NIH) Feedback Sessions in Washington D.C. on February 28, 2012.

The Feedback Sessions are an invitation only program funded by the NIH in cooperation with the Larta Institute (www.larta.org) called the SBIR Commercialization Assistance Program (CAP).  CAP exposes some of the nation's most promising small life science and healthcare companies and their technologies and business strategies to the investment community, strategic partners and licensees. 

NKI, with assistance from NIH and Larta, is presenting to investors, life science professionals and consultants, and corporate development officers at 8:30 Tuesday morning the 28th. 

"NKI is honored to be one of only forty companies selected to participate," said Vince Kytka, Director of Operations and Marketing. "This program is a great opportunity for accelerating our path to market."

NKI, poised for exciting growth, has had promising success with its I-Portal® technology to diagnose concussions, and, with the support of NIH's SBIR program, it is progressing in the development of its revolutionary I- Portal® Retinopathy product, a new, non-invasive ophthalmic diagnostic device. Initial data suggests this tool can provide early detection of diabetic retinopathy. 

"We are looking forward to this great opportunity to share our progress and potential with such a knowledgeable and influential group," added Howison Schroeder, President and CEO.

Admission to the sessions are limited and by invitation only. If you are interested in attending, please send your contact info to Tracey Zimmerman at tzimmerman@neuro-kinetics.com, or call (412) 963-6649. 

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (NKI) is the world leader in non-invasive diagnostics using its I-Portal® eye tracking technology. The eye is the portal to the brain and research has shown the detection of abnormal eye reflexes can indicate the presence of over 200 diseases and medical conditions.

For more than 25 years, NKI has supplied comprehensive neuro-otologic diagnostic tools to audiologists, ENTs, neuro-otologists, neuro-ophthalmologists and neurologists around the globe.  The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Iron-moving malfunction may underlie neurodegenerative diseases, aging
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. Stabilizing force for good communication between neurons and muscle cells found
4. Researchers identify promising gene target for neuroblastoma therapy
5. How neuronal activity leads to Alzheimers protein cleavage
6. Mediator in communication between neurons and muscle cells found
7. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
8. A double-barreled immune cell approach for neuroblastoma
9. Protecting neurons could halt Alzheimers, Parkinsons diseases
10. Neuroinformatics special issue spotlights the Neuroscience Information Framework
11. Bipolar disorder genes, pathways identified by Indiana University neuroscientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Cousins Properties (NYSE: CUZ ) announced today that ... a 10-year, approximately 125,000 square-foot lease at Corporate Center, a ... Westshore submarket of Tampa, FL. ... Center for their new location in Tampa ... officer of Cousins Properties. "Amgen is a cutting-edge global company ...
(Date:3/27/2017)... ROCKVILLE, Md. , March 27, 2017 /PRNewswire/ ... $108.5 billion for 2016, according to a new ... patients, medical lab testing is performed to evaluate ... determine individual therapy, among other reasons.  The healthcare ... Services Market , provides an overview of ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... PMG ... Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on April ... they collaborate to drive improved clinical trial outcomes and bring them closer to the ...
(Date:3/27/2017)... Israel , March 27, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... party insurance coverage option for U.S. consumers who want ... DarioHealth has signed strategic alliance agreements with ... verify insurance coverage benefits, and if approved, will supply ...
Breaking Biology Technology: